MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized form of lysergide D-tartrate, for the treatment of generalized anxiety ...
Ocugen OCGN is making rapid progress in its gene therapy programs for retinal diseases, which have differentiated mechanisms ...
For some American enthusiasts, 2026 can be a year to remember because it brings the possibility of importing these impressive ...
Modeled on a pair of 1957 watches, Vacheron Constantin’s latest 42.5mm Patrimony Moon Phase Retrograde Date ($58,000 in pink ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
Lada Gardens in Dededo will get 16 more low-income rental units renovated, Adelup said on Monday. A groundbreaking was held ...
NDA supported by results from a Phase II registration trial in China - - Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in comparison ...
As GCCs evolve into global innovation and decision-making hubs, flexible and managed workspaces are becoming ...